Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer

Journal of Nuclear Medicine

Volumn 40, Issue 10, 1999, Pages 1716-1721

  Ceccarelli, Claudia ^a   Battisti, Paolo ^b   Gasperi, Maurizio ^b   Fantuzzi, Elena ^b   Pacini, Furio ^b   Gualdrini, Gianfranco ^b   Pierantoni, Maria Cristina ^b   Luciani, Andrea ^b   Djokich, Darije ^b   Pinchera, Aldo ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

131I therapy; Differentiated thyroid cancer; Radiation dose; Testes dose

Indexed keywords

IODINE 131;

ADULT; ARTICLE; BETA RADIATION; CASE REPORT; GAMMA RADIATION; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; TESTIS; THERMOLUMINESCENCE DOSIMETRY; THYROID CANCER; THYROIDECTOMY; TUMOR DIFFERENTIATION;

ADMINISTRATION, ORAL; ADULT; COMBINED MODALITY THERAPY; FERTILITY; HUMANS; IODINE RADIOISOTOPES; IODOPROTEINS; MALE; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; TESTIS; THERMOLUMINESCENT DOSIMETRY; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS;

EID: 0032886951     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Handelsman DJ, Turtle JR. Testicular damage after radioactive iodine (1-131) therapy for thyroid cancer. Clin Endocrinol (Oxf). 1983;18:465-472.
2. Pacini F, Gasperi M, Fugazzola L, Ceccarelli C, Lippi F, Centoni R, et al. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J Nucl Med. 1994;35:1418-1422.
3. International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. ICRP publication 53. New York, NY: Pergamon Press; 1987:259-278.
4. Hlad CJ, Bricker NS. Renal function and I-131 clearance in hyperthyroidism and in myxedema. J Clin Endocrinol Metab. 1954;14:1539-1550.
5. Briesmeister JF, ed. MCNP: A General Monte Carlo N-Particle Transport Code LA-12625-M. Los Alamos, NM: Los Alamos National Laboratory. Group XTM; 1993.
6. International Commission on Radiological Units. Phantoms and computational models in therapy, diagnosis and protection. ICRU report 48. Bethesda, MD: International Commission on Radiological Units; 1992.
7. Kramer R, Zankl M, Williams G, Drexler G. The calculation of dose from external photon exposures using reference human phantoms and Monte Carlo methods. Part 1: The male (ADAMO) and female (EVA) adult mathematical phantoms. GSF-report S885. Neuherberg, Germany: Forschungszentrum für Umwelt und Gesundheit; 1992.
8. S Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs, MIRD pamphlet no. 11. New York. NY: Society of Nuclear Medicine; 1915.
9. International Commission on Radiological Protection. Report of the Task Group on Reference Man. ICRP publication 23. Oxford. UK: Pergamon Press; 1975.
10. International Commission on Radiological Protection. Radionuclide Transformation. ICRP publication 38. Oxford, UK: Pergamon Press; 1983.
11. Aghini Lombardi F, Antonangeli L, Vitti P, Pinchera A. Status of iodine nutrition in Italy. In: DeLange F, Dun JT, Glinoer D, eds. Iodine Deficiency in Europe. A Continuing Concern, vol. 241. New York, NY: Plenum Press; 1993:403-408.
12. Robertson JS, Gorman CA. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J Nucl Med. 1976;17:826-835.
13. Casalini L. Monte Carlo calculation with the anthropomorphic ADAMO phantom to evaluate the dose to the testes due to gamma radiation from thyroid remnants after therapeutic administration of I-131 to thyroidectomized patients [in Italian]. ENEA report 10/94. Bologna, Italy: Italian Agency for New Technologies, Energy and Environment; 1994.
14. Izembart M, Chauvadra J, Aubert B, Vallée G. Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer. Eur J Nucl Med. 1992;19:243-247.
15. 131I in the treatment of thyroid cancer. Thyroid Today. 1993;16:1-9.
16. Schlumherger M, DeVathaire F, Ceccarelli C, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med. 1996;37:606-612.
17. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995;36:21-27.